Keywords: فارماکودینامیک; GLP-1 receptor agonist; pharmacodynamics; phase I; AUC24; Area under the plasma concentration time curve from 0 to 24 hours afterdose in steady state; BMI; Body mass index; CL/F; Apparent clearance; Ctrough; Trough concentration; FPG; Fasting plasma gluco
مقالات ISI فارماکودینامیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکودینامیک; TCM; traditional Chinese medicine; PK; pharmacokinetics; PD; pharmacodynamics; FA; ferulic acid; GA; glycyrrhetinic acid; P-gp; P-glycoprotein; B; Angelica sinensis (Oliv.) Diels, radix; C; Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsi
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Fludarabine; Pediatric; Allogeneic; Hematopoietic cell transplantation;
Keywords: فارماکودینامیک; Burn; Antimicrobials; Sepsis; Infections; Biomarkers; Pharmacokinetics; Pharmacodynamics; Dosing;
Keywords: فارماکودینامیک; glucagon-like peptide 2; intestinal failure; pediatric short bowel syndrome; short gut syndrome; AE; Adverse event; EN; Enteral nutrition; GI; Gastrointestinal; GLP; Glucagon-like peptide; IF; Intestinal failure; ITT; Intent-to-treat; PD; Pharmacodynamics
Keywords: فارماکودینامیک; Angiogenesis inhibitors; Neovascularization; Pharmacokinetics; Pharmacodynamics; Protein kinase inhibitors; Monoclonal antibodies;
Keywords: فارماکودینامیک; agonist; elderly; hepatic; obesity; pharmacodynamics; pharmacokinetics; receptor; renal; serotonin; weight loss;
Keywords: فارماکودینامیک; Hydroxyurea (HU); Sickle cell anemia (SCA); Pharmacometrics; D-optimal design; Bayesian individualized dosing; SCA; sickle cell anemia; MTD; maximum tolerated dose; PK; pharmacokinetics; PD; pharmacodynamics; AUC; area under the concentration-time curve;
Keywords: فارماکودینامیک; Spaceflight; Microgravity; Astronaut; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Obese children; Model-informed doing; Prediction in pharmacology;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Multi-scale systems biology; Quantitative systems pharmacology;
Keywords: فارماکودینامیک; Clinical pharmacology; Drug development; Modelling; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; Hyaluronan; Ocular drug delivery; Drug-polyelectrolyte complex; Pharmacokinetics; Pharmacodynamics; Pre-corneal residence time; Glaucoma treatment;
Keywords: فارماکودینامیک; Antibiotic resistance; Bacteriophage; Encapsulation; Phage therapy; Pharmacodynamics;
Keywords: فارماکودینامیک; Depth of hypnosis control; PID Control; Event-based control; Noise filtering; AEP; auditory evoked potential; BIS; bispectral index scale; BIS-NADIR; lowest value of the bispectral index scale; DoH; depth of hypnosis; EEG; electroencephalogram; IAE; integ
Keywords: فارماکودینامیک; intracellular drug crystals; granulomas; metabolomics; microbiome; pharmacodynamics; pharmacometabolomics; nuclear magnetic resonance;
Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism
Keywords: فارماکودینامیک; Methylprednisolone; Liver; Pharmacoproteomics; Functional proteomics; Pharmacodynamics;
Keywords: فارماکودینامیک; PACA; poly(alkyl cyanoacrylate); CsA; cyclosporine A; IOBA-NHC; spontaneously immortalized epithelial cell line from normal human conjunctiva; HCE; human corneal epithelial cells; FITC; fluorescein isothiocyanate; HA; hyaluronic acid; IOP; intraocular pre
Keywords: فارماکودینامیک; Caffeine; Systematic review; Safety; Pregnancy; Coffee; Behavior; ADHD; attention deficit hyperactivity disorder; AHRQ; Agency for Healthcare Research and Quality; BMC; bone mineral content; BMD; bone mineral density; BMI; body mass index; CDC; US Centers
Keywords: فارماکودینامیک; Drug efficacy; drug safety; individual variability; personalized medicine; pharmacodynamics; pharmacogenetics; pharmacogenomics; pharmacokinetics; precision medicine; stratified medicine
Keywords: فارماکودینامیک; Beta-lactam; Pharmacokinetics; Continuous-infusion; Prolonged infusion; Pseudomonas aeruginosa; Pharmacodynamics;
Keywords: فارماکودینامیک; Cytochrome P450; drug interactions; P-glycoprotein; pharmacodynamics; pharmacokinetics; polypharmacy
Keywords: فارماکودینامیک; MRSE; Pharmacokinetics; Pharmacodynamics; Foreign-body infection; Systemic infection;
Keywords: فارماکودینامیک; Adverse drug reactions; ageing; frailty; pharmacodynamics; pharmacokinetics; prescribing
Keywords: فارماکودینامیک; Rabeprazole; Metformin; Transporter; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; global health; big data; pharmacodynamics; systems pharmacology;
Keywords: فارماکودینامیک; Affinity; agonist; antagonist; desensitization; dose–response curve; pharmacodynamics; receptors; selectivity; therapeutic index
Keywords: فارماکودینامیک; Erythropoiesis; Hypoxia-inducible-factor; Pharmacokinetics; Pharmacodynamics; Toxicity;
Keywords: فارماکودینامیک; Pharmacodynamics; Biomarkers; Biopsy surrogate tissues; Phase I; Drug evaluation;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Meropenem; Children; Severe infection;
Keywords: فارماکودینامیک; Immunosuppression; Therapeutic drug monitoring; Pharmacodynamics; Biomarker
Keywords: فارماکودینامیک; Biologic; Biosimilar; Biosimilarity; Characterization; Chronic inflammatory diseases; Clinical; Comparability; Development; Functional; Immunogenicity; Innovator; Manufacturing; Pharmacodynamics; Pharmacokinetics; Preclinical; Quality; Reference product;
Keywords: فارماکودینامیک; Rifampicin; Pharmacokinetics; Pharmacodynamics; Staphylococcus aureus
Keywords: فارماکودینامیک; Pharmacokinetics; Pediatrics; Pharmacodynamics; Aminoglycoside; Paracetamol; Beta-blockers
Keywords: فارماکودینامیک; Esomeprazole; Immediate release; Ex vivo permeability; Rats; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; Oxycodone; Hydrocodone; Opioids; Pharmacology; Pharmacokinetics; Pharmacodynamics; Gender difference
Keywords: فارماکودینامیک; nanotechnology; oral drug delivery; drug transport; dissolution; physical characterization; stabilization; bioavailability; oral absorption; pharmacokinetics; pharmacodynamics;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Cardiovascular drugs; Chronic heart failure;
Keywords: فارماکودینامیک; Eicosapentaenoic acid; Hypertriglyceridemia; Icosapent ethyl; Pharmacodynamics; Triglycerides;
Keywords: فارماکودینامیک; Obesity; Non-obese patients; β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Fluconazole; Cryptococcus gattii; Resistance;
Keywords: فارماکودینامیک; Hydrogel; Liposome; Doxorubicin; Pharmacodynamics; Pharmacokinetics;
Keywords: فارماکودینامیک; Inhibidores del factor Xa; Farmacocinética; Farmacodinamia; Esquema de administración; Fibrilación auricular; Factor Xa inhibitors; Pharmacokinetics; Pharmacodynamics; Administration regimen; Atrial fibrillation;
Keywords: فارماکودینامیک; Factor Xa inhibitors; Pharmacokinetics; Pharmacodynamics; Administration regimen; Atrial fibrillation; Inhibidores del factor Xa; Farmacocinética; Farmacodinamia; Esquema de administración; Fibrilación auricular;
Keywords: فارماکودینامیک; TIA; transient ischemic attack; RCT; randomized controlled trials; MI; myocardial infarction; DAPT; dual antiplatelet therapy; PAR; protease-activated receptor; DDIs; drug-drug interactions; PD; pharmacodynamics; PK; pharmacokinetics; TX; thromboxane; AA;
Keywords: فارماکودینامیک; Antifungal; Fluconazole; Pharmacodynamics; Non-obese patients; Obesity; Morbidly obese patients;
Keywords: فارماکودینامیک; Intracellular drug concentration; Pharmacodynamics; OCT; MATE; PMAT; Drug transporter; ABC; ATP-binding cassette; ACC; acetyl-CoA carboxylase; AMP; adenosine monophosphate; AMPK; AMP-activated protein kinase; AUC; area under the concentration time curve;
Keywords: فارماکودینامیک; drug-drug interaction; pharmacodynamics; pharmacokinetics; selexipag; warfarin;
Keywords: فارماکودینامیک; microdialysis; open flow microperfusion; macromolecules; pharmacokinetics; pharmacodynamics; monoclonal antibodies; interstitial fluid; IL; interleukin; NGF; nerve growth factor; VEGF; vascular endothelial growth factor;
Keywords: فارماکودینامیک; Pharmacological audit trail; Biomarkers; Pharmacodynamics; Pharmacokinetics;